Camp4 Therapeutics Corp - Common Stock, par value $0.0001 per share (CAMP)

Historical Holders from Q4 2024 to Q3 2025

Symbol
CAMP on Nasdaq
CUSIP
13463J101
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
46.6M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
28.2M
Holdings value
$84.6M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
28
Number of buys
13
Number of sells
-16
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Camp4 Therapeutics Corp - Common Stock, par value $0.0001 per share (CAMP)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
5AM Ventures VI, L.P. 12.5% $11.9M 5.87M Andrew J. Schwab Sep 9, 2025
Coastlands Capital LP 10% $9.87M 4.89M Coastlands Capital LP Sep 10, 2025
Polaris Management Co. VII, L.L.C. 8.4% $7.94M 3.93M Amir Nashat Sep 9, 2025
Enavate Sciences GP, LLC 8.1% $7.65M 3.79M Enavate Sciences GP, LLC Sep 11, 2025
Vivo Opportunity Fund Holdings, L.P. 7.6% $7.19M 3.56M Vivo Opportunity Fund Holdings, L.P. Sep 11, 2025
FMR LLC 6.7% -55.3% $9.66M $375K 3.15M +4.04% FMR LLC Oct 31, 2025
Northpond Ventures II, LP 4.8% $6.87M 2.24M Michael P. Rubin Sep 30, 2025
AH Bio Fund I, L.P. 4.5% $6.52M 2.13M Marc L. Andreessen Sep 30, 2025
HARBOURVEST PARTNERS LLC 2.7% -60% $3.54M 1.27M 0% HarbourVest Partners L.P. Sep 30, 2025

Institutional Holders of Camp4 Therapeutics Corp - Common Stock, par value $0.0001 per share (CAMP)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 28.2M $84.6M +$49.5M $3.00 28
2025 Q2 11.7M $17M -$3.22M $1.45 28
2025 Q1 12.7M $50.7M -$1M $4.00 39
2024 Q4 12.9M $67.1M +$47.3M $5.22 36